PharmaBoardroom

Aducanumab: On the Regulatory Home Stretch in the USA

In the third of a series of articles chronicling Biogen/Eisai’s Alzheimer’s Disease (AD) treatment aducanumab’s torturous journey to market, Dr…

Chinese Biotech Strategies: The Pros & Cons of In-Licensing

Since the Chinese biopharma boom started in the late-2000s, Chinese biotechs have seen in-licensing as a shortcut to establishing their own portfolios…

US Biotech Commercialisation Strategies: How Karyopharm &…

With US still the reigning global champion in biotech innovation, the dynamic and vibrant biopharma ecosystem in the world’s largest healthcare…

Top 10 Pharma Companies in Saudi Arabia

The top 10 pharma companies in Saudi Arabia ranked by sales value in USD millions MAT Q1 2019. These top 10 corporations account for 50 percent of…

Latin America COVID-19 News Roundup September 2020

The latest from the fight against COVID-19 in Latin America, including J&J’s vaccine trials, issues surrounding Chinese-made diagnostic tests,…

Middle East & Africa Pharma News Roundup September 2020

A roundup of the latest news from pharma in the Middle East and Africa including China’s announcement that it will be prioritising Africa for access…

Five Norwegian Medtechs to Watch

Norway, known more for its expertise in oil and gas and marine biology than in health innovation, is home to increasing numbers of innovative medical…

Canada Pharma News Roundup September 2020

The latest news from Canadian pharma including deals for J&J’s and Novavax’s COVID-19 vaccines, an abrupt end to Canada’s participation in…

Joong Myung Cho – Chairman & CEO, CrystalGenomics,…

Joong Myung Cho of Korean biotech success story CrystalGenomics introduces the company’s unique drug discovery platform, key growth factors, highly…

Michael G. Kauffman – Founder & CEO, Karyopharm…

Karyopharm Therapeutics’ Dr Michael G. Kauffman outlines the genesis of the company he co-founded with his wife, the approval journey of key product…

China Pharma News Roundup September 2020

The latest from Chinese pharma, including a setback for CanSinoBIO’s Canadian COVID-19 vaccine trial, Bayer’s new Beijing manufacturing plant, and…

Kerry Blanchard – CEO, Everest Medicines, China

Dr Kerry Blanchard explains why he took on the challenge of becoming CEO of Chinese biotech Everest Medicines and how Everest’s internationalist…

Tagged with BI